These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26646090)

  • 21. [Prevention of gastrointestinal cancer].
    Teufel A; Quante M; Kandulski A; Hirth M; Zhan T; Eckardt M; Thieme R; Kusnik A; Yesmembetov K; Wiest I; Riemann JF; Schlitt HJ; Gockel I; Malfertheiner P; Ebert MP
    Z Gastroenterol; 2021 Sep; 59(9):964-982. PubMed ID: 34507375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends and challenges in immuno-oncology trials.
    Kiernan B
    Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From the meeting: Orlando plays host to the 2017 ASCO Genitourinary Cancer symposium.
    Fenner A
    Nat Rev Urol; 2017 Apr; 14(4):199. PubMed ID: 28290458
    [No Abstract]   [Full Text] [Related]  

  • 24. [ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].
    Ettrich TJ; Ebert M; Lorenzen S; Moehler M; Vogel A; Witkowski L; Seufferlein T; Reinacher-Schick A
    Z Gastroenterol; 2018 Apr; 56(4):384-397. PubMed ID: 29642252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
    Moehler M; Delic M; Goepfert K; Aust D; Grabsch HI; Halama N; Heinrich B; Julie C; Lordick F; Lutz MP; Mauer M; Alsina Maqueda M; Schild H; Schimanski CC; Wagner AD; Roth A; Ducreux M
    Eur J Cancer; 2016 May; 59():160-170. PubMed ID: 27039171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASCO 2015 update on melanoma.
    Carson WE
    Surg Oncol; 2015 Dec; 24(4):363-5. PubMed ID: 26564261
    [No Abstract]   [Full Text] [Related]  

  • 27. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastrointestinal oncology].
    Stiefelhagen P
    Internist (Berl); 2005 Feb; 46(2):216-25. PubMed ID: 15655683
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.
    Mayer RJ; Venook AP; Schilsky RL
    J Clin Oncol; 2014 May; 32(15):1521-30. PubMed ID: 24752046
    [No Abstract]   [Full Text] [Related]  

  • 30. Secondary cancer prevention: the clinico-pathological priority for the next decade.
    Rugge M
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):157-8. PubMed ID: 23809237
    [No Abstract]   [Full Text] [Related]  

  • 31. Update for ASCO 2015 sarcoma sessions.
    Karakousis G
    Surg Oncol; 2015 Dec; 24(4):369-70. PubMed ID: 26298199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of endoscopic studies in prevention and early diagnosis of malignant gastrointestinal tumors].
    Klassen M
    Vestn Ross Akad Med Nauk; 1998; (4):7-10. PubMed ID: 9633232
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gastroenterology: in the vanguard of the prevention of cancer (opinion of Prof. M. Crespi].
    Crespi M
    Minerva Gastroenterol; 1972; 18(2):97-100. PubMed ID: 4680172
    [No Abstract]   [Full Text] [Related]  

  • 34. [ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, 26-28 January 2006].
    Tumori; 2006; 92(2):1-20. PubMed ID: 16724704
    [No Abstract]   [Full Text] [Related]  

  • 35. A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator.
    Hoffman A; Manner H; Rey JW; Kiesslich R
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(7):421-434. PubMed ID: 28611477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of gastrointestinal malignancies].
    Hoffmeister A; Schiefke I; Teich N; Mössner J; Schoppmeyer K
    Internist (Berl); 2008 Feb; 49(2):178-84. PubMed ID: 18210023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers of increased susceptibility to gastrointestinal cancer. Their development and application to studies of cancer prevention.
    Lipkin M
    Gastroenterology; 1987 Apr; 92(4):1083-6. PubMed ID: 3549422
    [No Abstract]   [Full Text] [Related]  

  • 38. The relationship between introduction of American society of clinical oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital.
    Debrix I; Tilleul P; Milleron B; Grené N; Bouleuc C; Roux D; Lioté H; Madelaine I; Bellanger A; Conort O; Fontan JE; Le Mercier F; Bardin C; Becker A
    Clin Ther; 2001 Jul; 23(7):1116-27. PubMed ID: 11519774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Are the "4P" clinical strategies against gastrointestinal tumors still far away?].
    Gao HJ; Guo Y
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):286-7. PubMed ID: 20627030
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention and screening of gastrointestinal cancers.
    Mahon SM
    Semin Oncol Nurs; 2009 Feb; 25(1):15-31. PubMed ID: 19217503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.